Cargando…
Targeting codon 158 p53-mutant cancers via the induction of p53 acetylation
Gain of function (GOF) DNA binding domain (DBD) mutations of TP53 upregulate chromatin regulatory genes that promote genome-wide histone methylation and acetylation. Here, we therapeutically exploit the oncogenic GOF mechanisms of p53 codon 158 (Arg(158)) mutation, a DBD mutant found to be prevalent...
Autores principales: | Kong, Li Ren, Ong, Richard Weijie, Tan, Tuan Zea, Mohamed Salleh, Nur Afiqah Binte, Thangavelu, Matan, Chan, Jane Vin, Koh, Lie Yong Judice, Periyasamy, Giridharan, Lau, Jieying Amelia, Le, Thi Bich Uyen, Wang, Lingzhi, Lee, Miyoung, Kannan, Srinivasaraghavan, Verma, Chandra S., Lim, Chwee Ming, Chng, Wee Joo, Lane, David P., Venkitaraman, Ashok, Hung, Huynh The, Cheok, Chit Fang, Goh, Boon Cher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7190866/ https://www.ncbi.nlm.nih.gov/pubmed/32350249 http://dx.doi.org/10.1038/s41467-020-15608-y |
Ejemplares similares
-
Drugging in the absence of p53
por: Aning, Obed Akwasi, et al.
Publicado: (2019) -
The p53 inducing drug dosage may determine quiescence or senescence
por: Lane, David P., et al.
Publicado: (2010) -
Activation of p53: How phosphorylated Ser15 triggers sequential phosphorylation of p53 at Thr18 by CK1δ
por: Nicolaou, Sonia T., et al.
Publicado: (2022) -
Long range recognition and selection in IDPs: the interactions of the C-terminus of p53
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2016) -
The Dual Interactions of p53 with MDM2 and p300: Implications for the Design of MDM2 Inhibitors
por: Kannan, Srinivasaraghavan, et al.
Publicado: (2019)